Elsevier signs agreement with California Digital Library

Mutually beneficial deal brings scientific and medical information to the University of California system.

Mutually beneficial deal brings scientific and medical information to the University of California system

San Diego, 10 January 2004 – Shortly before the opening of the American Library Association Midwinter Meeting, Elsevier announced that it signed a 5-year agreement with the California Digital Library (CDL), after several months of intense negotiations. 

The agreement provides over 300,000 University of California (UC) undergraduates, graduates, researchers, faculty and staff with access to the UC list of subscribed titles, all Cell Press titles and Elsevier's entire collection of backfiles for all subject areas, back to Volume 1, Issue 1 which alone comprises 3 million articles. 

The agreement relating to the subscribed titles list provides the UC user community with access to approximately 3.6 million full-text articles and 59 million abstracts. Furthermore, the agreement contains the standard Elsevier "walk-up" provision, which permits all California citizens coming to UC libraries for scientific and medical information, free access to content covered under the agreement. 

Although the negotiation period was challenging for both parties, the tone of the discussion was professional and cordial throughout. "This agreement provides access for researchers to the critical scientific content determined by UC librarians over the past few months. The conclusion of the agreement now allows both sides to focus their energies on new areas for cooperation. We would like to thank the CDL negotiating team for their efforts," said Frank Vrancken Peeters, Elsevier's Managing Director for Sales, Science & Technology, Elsevier

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact:

Eric Merkel-Sobotta
Director, Corporate Relations of Elsevier
Tel: +31-20-485-29-94
Mobile: +31-651-53-24-12
Fax: +31-20-485-28-43
e.merkelsobotta@elsevier.com